|
1
|
Yan PS, Shi H, Rahmatpanah F, Hsiau TH,
Hsiau AH, Leu YW, Liu JC and Huang TH: Differential distribution of
DNA methylation within the RASSF1A CpG island in breast cancer.
Cancer Res. 63:6178–6186. 2003.PubMed/NCBI
|
|
2
|
Zabarovsky ER, Lerman MI and Minna JD:
Tumor suppressor genes on chromosome 3p involved in the
pathogenesis of lung and other cancers. Oncogene. 21:6915–6935.
2002. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Maitra A, Wistuba II, Washington C,
Virmani AK, Ashfaq R, Milchgrub S, Gazdar AF and Minna JD:
High-resolution chromosome 3p allelotyping of breast carcinomas and
precursor lesions demonstrates frequent loss of heterozygosity and
a discontinuous pattern of allele loss. Am J Pathol. 159:119–130.
2001. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Miller BJ, Wang D, Krahe R and Wright FA:
Pooled analysis of loss of heterozygosity in breast cancer: A
genome scan provides comparative evidence for multiple tumor
suppressors and identifies novel candidate regions. Am J Hum genet.
73:748–767. 2003. View
Article : Google Scholar : PubMed/NCBI
|
|
5
|
Yang Q, Yoshimura G, Mori I, Sakurai T and
Kakudo K: Chromosome 3p and breast cancer. J Hum genet. 47:453–459.
2002. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Lerman MI and Minna JD: The 630-kb lung
cancer homozygous deletion region on human chromosome 3p21.3:
Identification and evaluation of the resident candidate tumor
suppressor genes. The International Lung Cancer Chromosome 3p213
Tumor Suppressor Gene Consortium. Cancer Res. 60:6116–6133.
2000.PubMed/NCBI
|
|
7
|
Wistuba II, Gazdar AF and Minna JD:
Molecular genetics of small cell lung carcinoma. Semin Oncol.
28(Suppl 4): S3–S13. 2001. View Article : Google Scholar
|
|
8
|
Minna JD, Fong K, Zöchbauer-Müller S and
Gazdar AF: Molecular pathogenesis of lung cancer and potential
translational applications. Cancer J. 8(Suppl 1): S41–S46.
2002.PubMed/NCBI
|
|
9
|
Sekido Y, Fong KM and Minna JD: Molecular
genetics of lung cancer. Annu Rev Med. 54:73–87. 2003. View Article : Google Scholar
|
|
10
|
Ji L and Roth JA: Tumor suppressor FUS1
signaling pathway. J Thorac Oncol. 3:327–330. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Prudkin L, Behrens C, Liu DD, Zhou X,
Ozburn NC, Bekele BN, Minna JD, Moran C, Roth JA, Ji L, et al: Loss
and reduction of FUS1 protein expression is a frequent phenomenon
in the pathogenesis of lung cancer. Clin Cancer Res. 14:41–47.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Ivanova AV, Ivanov SV, Pascal V, Lumsden
JM, Ward JM, Morris N, Tessarolo L, Anderson SK and Lerman MI:
Autoimmunity, spontaneous tumourigenesis, and IL-15 insufficiency
in mice with a targeted disruption of the tumour suppressor gene
Fus1. J Pathol. 211:591–601. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Degli-Esposti MA and Smyth MJ: Close
encounters of different kinds: Dendritic cells and NK cells take
centre stage. Nat Rev Immunol. 5:112–124. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Vosshenrich CA, Ranson T, Samson SI,
Corcuff E, Colucci F, Rosmaraki EE and Di Santo JP: Roles for
common cytokine receptor gamma-chain-dependent cytokines in the
generation, differentiation, and maturation of NK cell precursors
and peripheral NK cells in vivo. J Immunol. 174:1213–1221. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Williams NS, Klem J, Puzanov IJ, Sivakumar
PV, Schatzle JD, Bennett M and Kumar V: Natural killer cell
differentiation: Insights from knockout and transgenic mouse models
and in vitro systems. Immunol Rev. 165:47–61. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Fehniger TA and Caligiuri MA: Interleukin
15: Biology and relevance to human disease. Blood. 97:14–32. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Ji L, Nishizaki M, Gao B, Burbee D, Kondo
M, Kamibayashi C, Xu K, Yen N, Atkinson EN, Fang B, et al:
Expression of several genes in the human chromosome 3p21.3
homozygous deletion region by an adenovirus vector results in tumor
suppressor activities in vitro and in vivo. Cancer Res.
62:2715–2720. 2002.PubMed/NCBI
|
|
18
|
Baek D, Villén J, Shin C, Camargo FD, Gygi
SP and Bartel DP: The impact of microRNAs on protein output.
Nature. 455:64–71. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Corsten MF, Miranda R, Kasmieh R,
Krichevsky AM, Weissleder R and Shah K: MicroRNA-21 knockdown
disrupts glioma growth in vivo and displays synergistic
cytotoxicity with neural precursor cell delivered S-TRAIL in human
gliomas. Cancer Res. 67:8994–9000. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Guessous F, Zhang Y, Kofman A, Catania A,
Li Y, Schiff D, Purow B and Abounader R: microRNA-34a is tumor
suppressive in brain tumors and glioma stem cells. Cell Cycle.
9:1031–1036. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Chen G, Zhu W, Shi D, Lv L, Zhang C, Liu P
and Hu W: MicroRNA-181a sensitizes human malignant glioma U87MG
cells to radiation by targeting Bcl-2. Oncol Rep. 23:997–1003.
2010.PubMed/NCBI
|
|
22
|
Bacus SS, Zelnick CR, Plowman G and Yarden
Y: Expression of the erbB-2 family of growth factor receptors and
their ligands in breast cancers. Implication for tumor biology and
clinical behavior. Am J Clin Pathol. 102(Suppl 1): S13–S24.
1994.PubMed/NCBI
|
|
23
|
Liao XH, Lu DL, Wang N, Liu LY, Wang Y, Li
YQ, Yan TB, Sun XG, Hu P and Zhang TC: Estrogen receptor α mediates
proliferation of breast cancer MCF-7 cells via a
p21/PCNA/E2F1-dependent pathway. FEBS J. 281:927–942. 2014.
View Article : Google Scholar
|
|
24
|
Ma L, Teruya-Feldstein J and Weinberg RA:
Tumour invasion and metastasis initiated by microRNA-10b in breast
cancer. Nature. 449:682–688. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Ohgaki H and Kleihues P: Genetic pathways
to primary and secondary glioblastoma. Am J Pathol. 170:1445–1453.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
He L, He X, Lim LP, de Stanchina E, Xuan
Z, Liang Y, Xue W, Zender L, Magnus J, Ridzon D, et al: A microRNA
component of the p53 tumour suppressor network. Nature.
447:1130–1134. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Novakova J, Slaby O, Vyzula R and Michalek
J: MicroRNA involvement in glioblastoma pathogenesis. Biochem
Biophys Res Commun. 386:1–5. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Sasayama T, Nishihara M, Kondoh T, Hosoda
K and Kohmura E: MicroRNA-10b is overexpressed in malignant glioma
and associated with tumor invasive factors, uPAR and RhoC. Int J
Cancer. 125:1407–1413. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Sana J, Hajduch M, Michalek J, Vyzula R
and Slaby O: MicroRNAs and glioblastoma: Roles in core signalling
pathways and potential clinical implications. J Cell Mol Med.
15:1636–1644. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Du L, Schageman JJ, Subauste MC, Saber B,
Hammond SM, Prudkin L, Wistuba II, Ji L, Roth JA, Minna JD, et al:
miR-93, miR-98, and miR-197 regulate expression of tumor suppressor
gene FUS1. Mol Cancer Res. 7:1234–1243. 2009. View Article : Google Scholar : PubMed/NCBI
|
